On the one hand, the PI3K, HIF-1, and C-MYC signaling pathways can activate the expression of key glycolysis enzymes and transporters to ensure cancer metabolism and energy supply; on the other hand, the key enzymes and transporters of glycolysis can activate chemoresistance-related signaling pathways through their own or other protein mediators. The gene discussed is HIF1A; the disease is cancer.